title: [Effects of triptolide on the expression of androgen receptor in human prostate LNCaP cells and its mechanism of action].
abstract: To study the regulation of androgen receptor (AR) expression in human prostate cancer LNCaP cells by triptolide (TP) and the possible mechanism, by using qRT-PCR and Western blot, the AR mRNA and protein levels in TP treated LNCaP cells were detected, and the AR protein level in TP and NF-κB inhibitor treated LNCaP cells was also detected; a series of pGL3-AR promoter reporter gene vectors were built using restriction-free cloning method, and the vectors were employed to investigate the effects of TP on the transcriptional activity of AR promoter in LNCaP cells; the upstream proteins which may play regulatory roles were detected using western blot assay. After treated LNCaP cells with TP for 48 h, AR mRNA and protein expressions decreased with increasing TP concentration. The expression of AR target gene PART1 and prostate specific antigen (PSA) was also downregulated by TP treatment; a series of pGL3-AR promoter reporter vectors were constructed and validated by sequencing and luciferase activity; the results of dual luciferase reporter assay showed that TP downregulated AR at the transcriptional level; PI3K/AKT/NF-κB pathway which is associated with AR promoter activity was drowregulated by TP. In conclusion, our results demonstrated that the transcriptional activity of AR in LNCAP cells was downregulated by TP, and PI3K/AKT/NF-κB pathway may be involved in the regulation mechanism.
authors.forename: Bi-de
authors.initials: BD
authors.lastname: Liu
authors.forename: Qian-qian
authors.initials: QQ
authors.lastname: Feng
authors.forename: Xiao
authors.initials: X
authors.lastname: Gu
authors.forename: Dan
authors.initials: D
authors.lastname: Lu
authors.forename: Wei
authors.initials: W
authors.lastname: Li
mesh_terms: D045744:Cell Line, Tumor; D004224:Diterpenes / Q000494:pharmacology*; D015536:Down-Regulation; D004852:Epoxy Compounds / Q000494:pharmacology; D005822:Genetic Vectors; D006801:Humans; D008297:Male; D016328:NF-kappa B / Q000037:antagonists & inhibitors; D010616:Phenanthrenes / Q000494:pharmacology*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D011401:Promoter Regions, Genetic; D017430:Prostate-Specific Antigen / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000378:metabolism*; D012333:RNA, Messenger; D011944:Receptors, Androgen / Q000378:metabolism*; D015398:Signal Transduction; D015533:Transcriptional Activation
chemical_list: C410798:AR protein, human; D004224:Diterpenes; D004852:Epoxy Compounds; D016328:NF-kappa B; D010616:Phenanthrenes; D012333:RNA, Messenger; D011944:Receptors, Androgen; C001899:triptolide; D019869:Phosphatidylinositol 3-Kinases; D017430:Prostate-Specific Antigen